Table 8.
Follow-up period 1 (PODs 1–7)
| POD 1* | POD 2 | POD 3 | POD 4 | POD 5 | POD 6 | POD 7 | |
| Hb (g/L) | |||||||
| WBC (109/L) | |||||||
| PLT (109/L) | |||||||
| NEUT% | |||||||
| CRP (mg/L) | |||||||
| ALT (U/L) | |||||||
| AST (U/L) | |||||||
| Tbil (µmol/L) | |||||||
| LDH (U/L) | |||||||
| Crea (µmol/L) | |||||||
| ALB (g/L) | |||||||
| PA (mg/L) | |||||||
| ALP (U/L) | |||||||
| GGT (U/L) | |||||||
| PCT (ng/mL) | |||||||
| CK (U/L) | |||||||
| CK-MB (U/L) | |||||||
| Myoglobin (ng/mL) | |||||||
| High-sensitivity troponin (ng/mL) | |||||||
| Endotoxin (Eu/ml) | |||||||
| Serum amylase (U/L) | |||||||
| Serum lipase (U/L) | |||||||
| Ca2+ (mmol/L) | |||||||
| Serum cystatin (mg/L) | |||||||
| Urea (mmol/L) | |||||||
| Complement C1q (mg/L) | |||||||
| P2+ (mmol/L) | |||||||
| Retinol binding protein (mg/L) | |||||||
| BNP (pg/mL) | |||||||
| Ammonia (mg/L) | |||||||
| PT (S) | |||||||
| INR | |||||||
| Fbg (g/L) | |||||||
| D-Dimer (mg/L) | |||||||
| pH† | |||||||
| BE (mmol/L)† | |||||||
| Lac (mmol/L)† | |||||||
| PO2 (mm Hg)† | |||||||
| PCO2 (mm Hg)† | |||||||
| HCO3− (mmol/L)† | |||||||
| Collection of blood specimens | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y |
| Blood culture‡ | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y |
| US‡ | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y |
| Chest X-ray‡ | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y |
| Complications | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y |
| Adverse events | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y |
| Medication records | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y |
| Recipient survival status | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y |
| Graft survival status | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y | □0N□1Y |
Blood culture: when the patient's body temperature is above 38°C, blood culture should be carried out according to the patient's condition.
Complications, adverse events and medication records are recorded in detail in the case report form.
*Blood examination 5–11 hours after reperfusion.
†If the recipient is still in the ICU or needs arterial blood gas analysis.
‡Every other day within 1 week after operation.
ALB, albumin; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate transaminase; BE, base excess; BNP, brain natriuretic peptide; CK, creatine kinase; CK-MB, creatine kinaseisoenzyme; Crea, creatinine; CRP, C-reactive protein; Fbg, fibrinogen; GGT, glutamyl transpeptidase; Hb, haemoglobin; HCO3−, bicarbonate ion; INR, international normalized ratio; Lac, lactate; LDH, lactate dehydrogenase; NEUT%, neutrophilic granulocytepercentage; P2+, phosphonium ion; PA, prealbumin; PCO2, partial pressure of carbon dioxide; PCT, procalcitonin; pH, pondus hydrogenii; PLT, platelets; PO2, partial pressure of oxygen; PT, prothrombin time; Tbil, total bilirubin; US, ultrasound; WBC, white blood cells.